{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-052558","form_type":"8-K","ticker":"HNGE","cik":"0001673743","company_name":"Hinge Health, Inc.","filed_at":"2026-08-04T20:08:46+00:00","discovered_at":"2026-08-04T20:10:04.155490+00:00","generated_at":"2026-08-04T20:10:14.920185+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Hinge Health Q2 revenue $212.8M (+53% YoY), raises FY guidance, acquires Cylinder Health for $105M","bullets":["Revenue $212.8M (+53% YoY); GAAP EPS $0.52, non-GAAP EPS $0.59.","Free cash flow $99.6M, up 3x YoY; operating cash flow $101.4M.","FY 2026 revenue guidance raised to $856-860M (46% YoY growth at midpoint).","Acquired Cylinder Health for $105M cash; expands into gastrointestinal care; expected close Q3 2026.","Board increased share repurchase authorization by $300M to $496.5M total."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-052558","json":"https://secwatch.observer/filing/0001628280-26-052558.json","markdown":"https://secwatch.observer/filing/0001628280-26-052558.md","text":"https://secwatch.observer/filing/0001628280-26-052558.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1673743/000162828026052558/0001628280-26-052558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1673743/000162828026052558/hnge-20260729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:10:14.920185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}